HBV Citations List: May 2024

Literature Citations

1. Inhibition of Hepatitis B virus via Selective Apoptosis Modulation by Chinese Patent Medicine Liuweiwuling Tablet. Ge, F.L., Y. Yang, L.L. Si, Y.H. Li, M. Z. Cao, J. Wang, Z.F. Bai, Z.G. Ren, X.H. Xiao, and Y. Liu. World Journal of Gastroenterology, 2024. 30(13): p. 1911-1925. ISI[001208044900010].
[WOS]. HBV_05_2024.

2. Discovery and Mechanistic Study of Imperatorin that Inhibits HBsAg Expression and cccDNA Transcription. Ren, F., S. Zhao, X. He, H. Lo, V.K.W. Wong, B.Y.K. Law, A. Wu, and J. Zhang. Journal of Medical Virology, 2024. 96(5): p. e29669. PMID[38773784].
[PubMed]. HBV_05_2024.

3. Furanocoumarins Promote Proteasomal Degradation of Viral HBx Protein and Down-regulate cccDNA Transcription and Replication of Hepatitis B virus. Tyagi, P., A. Singh, J. Kumar, B. Ahmad, A. Bahuguna, P. Vivekanandan, S.K. Sarin, and V. Kumar. Virology, 2024. 595: p. 1-12. ISI[001221122300001]
[WOS]. HBV_05_2024.

Patent Citations

4. Modified short interfering nucleic acid (siNA) molecules and uses thereof. Beigelman, L., V.K. Rajwanshi, J. Hong, K. Passow, S.M. Montero, S.K. Thatikonda, and D.B. Smith. Patent. 2024. WO2023-US782242024097674: 375 pp.
[Patent]. HBV_05_2024.